Myelodysplastic syndromes (MDS) comprise the most common malignant blood disorder. MDS are increasing in frequency owing to an ageing population and increased awareness of these diseases.

Some cancer cells may build up in certain organs and cause organ-specific symptoms. »Learn more about Revlimid for multiple myeloma. Myelodysplastic syndrome is a type of cancer in the blood.

Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients ...

Myelodysplastic syndromes (MDS) include a group of hematopoietic malignancies characterized by dysplastic changes, ineffective hematopoiesis and variable risk of leukemic progression. At diagnosis ...

Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after ...